| Financial Year |
March 31 2023 |
| Monetary Funds |
504,184,775.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
119,804,528.34 |
| Accounts Receivable |
765,896,886.72 |
| Advances to Suppliers |
25,046,288.65 |
| Other Receivables |
33,439,582.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
903,309,350.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,380,353.86 |
| Total Current Assets |
2,430,664,139.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
140,980,743.66 |
| Investment Properties |
30,523,375.34 |
| Fixed Assetes |
115,053,865.43 |
| Under-construction Projects |
22,462,159.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
88,672,869.37 |
| R&D expenses |
-- |
| Goodwill |
308,849,650.04 |
| Long-Term Deferred and Prepaid Expenses |
6,305,007.87 |
| Deferred Income Tax Assets |
32,692,602.03 |
| Other Non-Current Assets |
10,783,061.40 |
| Sub-Total of Non-Current Assets |
822,306,076.25 |
| Total Assets |
3,252,970,216.24 |
| Short-Term Loans |
652,456,292.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
402,825,800.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,640,831.72 |
| Taxes Payable |
9,553,037.66 |
| Interest Payable |
-- |
| Dividend Payable |
6,403,882.57 |
| Other payables |
94,814,357.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
72,364,119.80 |
| Other Current Liabilities |
72,201,205.19 |
| Sub-Total of Current Liabilities |
1,342,109,014.45 |
| Long-term Loans |
25,471,725.75 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,095,750.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
59,532,000.44 |
| Total Liabilities |
1,401,641,014.89 |
| Paid-In Capital(Or Share Stock) |
1,137,597,085.00 |
| Capital Surplus |
273,439,428.15 |
| Surplus Reserve |
42,439,418.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
435,520,716.85 |
| Minority Stockholder's Interest |
-62,010,537.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,913,339,738.40 |
| Owner's Equity（Stockholder's Equity） |
1,851,329,201.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,252,970,216.24 |
